Xianheng International Science&Technology Co., Ltd.
605056.SS · SHH
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 2.12B | 829.08M | 290.63M | 206.90M | 0.52 |
| 2023 FY | 2.93B | 935.97M | 147.73M | 96.64M | 0.24 |
| 2024 FY | 3.61B | 1.06B | 315.80M | 222.93M | 0.55 |
| 2025 FY | 4.54B | 1.05B | 346.93M | 259.59M | 0.65 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 2.56B | 982.50M | 607.85M | 17.65M | 1.55B |
| 2023 FY | 2.97B | 1.37B | 819.09M | 73.75M | 1.57B |
| 2024 FY | 3.25B | 1.52B | 832.18M | 39.38M | 1.70B |
| 2025 FY | 4.01B | 2.17B | 688.35M | 279.83M | 1.81B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 215.24M | -31.27M | 183.97M | -140.00M | 133.08M |
| 2023 FY | 287.18M | -82.76M | 204.42M | -143.72M | 139.45M |
| 2024 FY | 288.78M | -97.84M | 190.93M | -61.70M | -51.95M |
| 2025 FY | 568.62M | -60.51M | 508.11M | -178.39M | -103.25M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 4.86B | 4.27B | — | — | — |
| 2023 FY | 6.28B | 5.53B | — | — | — |
| 2024 FY | 5.06B | 4.27B | — | — | — |
| 2025 FY | 6.59B | 6.18B | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q2 | 943.64M | 219.42M | 54.73M | 40.07M | 0.10 |
| 2025 Q3 | 1.11B | 240.36M | 93.42M | 66.56M | 0.18 |
| 2025 Q4 | 1.87B | 493.28M | 171.60M | 131.39M | 0.33 |
| 2026 Q1 | 878.64M | 151.01M | 28.00M | 26.00M | 0.06 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q2 | 3.00B | 1.35B | 572.81M | 80.51M | 1.62B |
| 2025 Q3 | 3.30B | 1.59B | 681.05M | 208.54M | 1.68B |
| 2025 Q4 | 4.01B | 2.17B | 688.35M | 279.83M | 1.81B |
| 2026 Q1 | 3.44B | 1.57B | 315.89M | 186.44M | 1.84B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | 1.91M | -17.99M | -16.08M | -145.78M | -42.11M |
| 2025 Q3 | 116.93M | -12.84M | 104.09M | — | 148.24M |
| 2025 Q4 | 587.97M | -12.68M | 575.29M | -178.39M | 7.31M |
| 2026 Q1 | -262.47M | -23.08M | -285.56M | -32.82M | -372.46M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q2 | 6.01B | 5.52B | — | — | — |
| 2025 Q3 | 6.16B | 5.69B | — | — | — |
| 2025 Q4 | 6.57B | 6.16B | — | — | — |
| 2026 Q1 | 9.80B | 9.68B | — | — | — |